Group 1: Share Buybacks and Acquisitions - WuXi AppTec plans to adjust the maximum repurchase price of its shares to no more than 114.15 yuan per share from the previous limit of 90.72 yuan per share, while other details of the repurchase plan remain unchanged [2] - ST Haihua's subsidiary intends to acquire 100% equity of Lvxin Dingsheng for 43 million yuan, citing the favorable development prospects of the natural gas industry [3] - Shenneng Power plans to repurchase shares for 300 million to 400 million yuan, with a maximum repurchase price of 38 yuan per share [4] - Huaneng Technology intends to acquire 6% of Jinghe Integrated's shares for 23.93 million yuan, with a transfer price of 19.88 yuan per share [7] Group 2: Financial Performance - Shijia Photon reported a net profit of 217 million yuan for the first half of 2025, a year-on-year increase of 1712%, with revenue of 993 million yuan, up 121.12% [5] - Enhua Pharmaceutical achieved a net profit of 700 million yuan in the first half of 2025, a year-on-year increase of 11.38%, with revenue of 3.01 billion yuan, up 8.93% [13] - Guangzhi Technology reported a net profit of 23.99 million yuan for the first half of 2025, marking a turnaround from losses, with revenue of 1.02 billion yuan, up 78.2% [10] Group 3: Market Activities and Listings - Binhua Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, currently discussing specific details with relevant intermediaries [8] - Tubaobao's subsidiary, Dehua Tubaobao Investment Management, holds a 2.05% stake in Hanhai Group, which is set to be listed on the Shenzhen Stock Exchange [12] - Changchun Gaoxin's subsidiary has received FDA approval for a hypertension drug, expanding its market presence in the U.S. [13]

公司结合业务实施情况对交易方案进行了优化和论证，并与皓天科技进行了多轮协商，但未能就核心条 款达成符合公司业务发展需要的一致意见。经公司审慎研究并与交易对方友好协商，拟终止本次对外投 资事项。 雅本化学（300261）(300261.SZ)公告，公司此前拟使用自有资金或/和自筹资金对外投资收购标的公司 甘肃皓天科技股份有限公司(简称"皓天科技")部分存量股份和/或认购皓天科技一定数量的新增注册资 本。通过该次交易，公司拟进一步利用包括但不限于表决权委托方式，实现对皓天科技的控制及并表。 ...

智通财经APP讯，雅本化学(300261.SZ)公告，公司此前拟使用自有资金或/和自筹资金对外投资收购标 的公司甘肃皓天科技股份有限公司(简称"皓天科技")部分存量股份和/或认购皓天科技一定数量的新增注 册资本。通过该次交易，公司拟进一步利用包括但不限于表决权委托方式，实现对皓天科技的控制及并 表。 公司结合业务实施情况对交易方案进行了优化和论证，并与皓天科技进行了多轮协商，但未能就核心条 款达成符合公司业务发展需要的一致意见。经公司审慎研究并与交易对方友好协商，拟终止本次对外投 资事项。 ...

人民财讯7月29日电，雅本化学（300261）7月29日晚间公告，公司原拟对外投资收购标的公司甘肃皓天 科技股份有限公司(简称"皓天科技")部分存量股份和/或认购皓天科技一定数量的新增注册资本，实现对 皓天科技的控制及并表。为了进一步响应客户需求，合理调配资金助力业务落地，切实维护公司及投资 者权益，经公司审慎研究并与交易对方友好协商，拟终止上述对外投资事项。 ...

本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 证券代码：300261 证券简称：雅本化学 公告编号：2025-057 雅本化学股份有限公司 关于拟终止筹划对外投资事项的提示性公告 一、本次筹划事项概述 雅本化学股份有限公司（以下简称"雅本化学"或"公司"）于2025年2月10 日披露《关于拟终止筹划对外投资的提示性公告》（以下简称"《提示性公告》"， 公告编号：2025-016），公司拟使用自有资金或/和自筹资金对外投资收购标的公司 甘肃皓天科技股份有限公司（以下简称"皓天科技"或"标的公司"）部分存量股 份和/或认购皓天科技一定数量的新增注册资本（以下简称"本次对外投资事项"或 "本次交易"）。通过本次交易，公司拟进一步利用包括但不限于表决权委托方式， 实现对皓天科技的控制及并表。 二、本次对外投资事项的进展情况 自《提示性公告》披露后，公司积极组织交易各方推进本次交易，联合专业中 介机构实施收购皓天科技的各项具体工作，包括尽职调查、财务审计以及交易方案 商谈等。公司结合业务实施情况对交易方案进行了优化和论证，并与皓天科技进行 了多轮协商，但未能就核心条 ...

雅本化学（300261）公告，公司拟终止筹划对外投资收购甘肃皓天科技股份有限公司部分存量股份和/ 或认购一定数量的新增注册资本。公司积极组织交易各方推进交易，但未能就核心条款达成一致意见。 终止事项不会对公司业务开展、生产经营活动和财务状况造成不利影响。 ...

Group 1: Company Overview and Strategy - The company is currently in the process of renewing its cooperation agreement with FMC, with ongoing discussions on relevant terms [1] - The company is implementing a "big customer strategy," transitioning to a diversified model with several core enterprise customers and multiple key innovative products [1][2] - The company has established long-term partnerships with leading pesticide companies, indicating a high entry barrier in the CDMO business [3] Group 2: Financial Performance and Challenges - The company reported a loss of 258 million yuan in 2024, primarily due to a goodwill impairment of 106 million yuan and a cyclical downturn in the pesticide industry [5] - The company’s short-term loans increased by 42.7%, with a debt ratio of 46.11%, but it maintains a strong repayment capability and has never defaulted [9] Group 3: Business Development and Future Plans - The company has a clear strategic plan for its pharmaceutical business, focusing on expanding GMP-compliant production capacity and maintaining a "big customer strategy" [7] - The Yancheng base is operational, with the second phase ready for use, expected to positively contribute to the pesticide business [8] - The company is cautiously expanding its health business, leveraging its synthetic biology and chemical synthesis technology platforms [10] Group 4: Research and Development - The company emphasizes a technology-driven development strategy, maintaining high R&D investment despite recent performance challenges [12] - The company aims to enhance its core competitiveness and build a solid technological barrier through continuous product development [12] Group 5: Shareholder Relations and Market Management - The company has not declared dividends for 2024 but maintains a positive attitude towards future dividend policies [13] - The company has implemented a market value management plan to enhance its business foundation and maintain investor relations [14]

[Current Period Performance Forecast](index=1&type=section&id=%E4%B8%80%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E8%AE%A1%E6%83%85%E5%86%B5) The company projects a significant reduction in net loss for the first half of 2025, with net profit attributable to shareholders expected to be a loss of 5 million to 10 million yuan, a substantial improvement from the prior year 2025 Semi-Annual Performance Forecast | Item | Current Period (Million Yuan) | Prior Year Period (Million Yuan) | | :--- | :--- | :--- | | **Net Profit Attributable to Shareholders of Listed Company** | Loss: 10.00 - 5.00 | Loss: 52.0136 | | **Net Profit After Deducting Non-Recurring Gains and Losses** | Loss: 22.00 - 17.00 | Loss: 49.4202 | [Pre-Audit Status of Performance Forecast](index=1&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E9%A2%84%E5%AE%A1%E8%AE%A1%E6%83%85%E5%86%B5) The company explicitly states that the financial data in this performance forecast remains unaudited by a certified public accountant - The financial data related to the company's performance forecast has **not been audited** by a certified public accountant[4](index=4&type=chunk) [Explanation of Performance Change](index=1&type=section&id=%E4%B8%89%E3%80%81%E4%B8%9A%E7%BB%A9%E5%8F%98%E5%8A%A8%E5%8E%9F%E5%9B%A0%E8%AF%B4%E6%98%8E) The company attributes the narrowing of its semi-annual loss to strategic focus on core business and deepened customer collaboration, anticipating single-quarter profitability in Q2 2025 before non-recurring items - The primary reasons for the company's improved performance and narrowed losses are its **sustained focus on core business**, **deepened customer cooperation**, and full implementation of its annual operating plan during the reporting period[5](index=5&type=chunk) - The company anticipates achieving **profitability before non-recurring items** in the **second quarter of 2025**, indicating a positive business trend[5](index=5&type=chunk) - The company's non-recurring gains and losses for the first half of 2025 are estimated to be approximately **12 million yuan**[5](index=5&type=chunk) [Other Relevant Information](index=1&type=section&id=%E5%9B%9B%E3%80%81%E5%85%B6%E4%BB%96%E7%9B%B8%E5%85%B3%E8%AF%B4%E6%98%8E) The company emphasizes that this performance forecast represents preliminary financial estimates, with final accurate data to be fully disclosed in the 2025 semi-annual report, advising investors to consider associated risks - This performance forecast is a preliminary estimate by the company's financial department, and the specific financial data will be subject to the **2025 semi-annual report**[6](index=6&type=chunk)

雅本化学（300261）公告，预计2025年1月1日至2025年6月30日期间，归属于上市公司股东的净利润为 亏损1000万元—500万元，较上年同期亏损减少。扣除非经常性损益后的净利润预计亏损2200万元— 1700万元，上年同期为亏损4942.02万元。公司2025年半年度非经常性损益约为1200万元。 ...

本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 雅本化学股份有限公司（以下简称"公司"）近日接到控股股东宁波雅本控 股有限公司（以下简称"宁波雅本"）的通知，宁波雅本将其持有的部分公司股 份办理了股份解除质押业务，具体事项如下： 证券代码：300261 证券简称：雅本化学 公告编号：2025-055 雅本化学股份有限公司 关于控股股东部分股份解除质押的公告 注：1、上表中蔡彤所持限售股份性质为高管锁定股；2、本公告中若出现总数与各分项 数值之和尾数不符的情况，均为四舍五入原因造成。 四、备查文件 二、股东股份累计质押的情况 截至本公告日，上述股东及其一致行动人所持质押股份情况如下： 股东名称 是否为控 股股东或 第一大股 东及其一 致行动人 本次解除 质押数量 （股） 占其所 持股份 比例 (%) 占公司 总股本 比例 (%) 质押起 始日 质押解 除日 质权人 宁波雅本 控股有限 公司 是 19,650,000 7.62 2.04 2022 年 7 月 18 日 2025 年 7 月 17 日 国 联 证 券 股份有限 公司 合计 - 19,650,000 7. ...